10 CFR 26.123

§ 26.123 Testing facility capabilities.

United States · 10 CFR — Energy · Status: effective

Cite this

Citation: 10 CFR 26.123, § 26.123 Testing facility capabilities, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/36672
Permanent ID: ys:prov:36672@1
SHA-256: 61de6603f49eedf7b0337dea1b368775fadd1118e48df709dfa8dd6155312d5c

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

Each licensee testing facility shall have the capability, at the same premises, to perform either validity screening tests or initial validity tests or both, and initial drug tests for each drug and drug metabolite for which testing is conducted.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.